InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Warner Brent, Président, Thérapie Génique. Director active across 1 company, notably Poseida Therapeutics, Inc.. In total, 3 filings have been logged. Activity tracked since 1 March 2022. The latest transaction was filed on 1 March 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Brent Warner is the President of Gene Therapy at Poseida Therapeutics, Inc. He leads the company's operations and strategy in the field of gene therapies. Poseida Therapeutics is a biopharmaceutical company specializing in developing innovative treatments. Warner's experience in the biopharmaceutical sector is essential for the company's success.